Successful allogeneic transplantation of patients with suspected prior invasive mold infection

References

• Offner F, Cordonnier C, Ljungman P, Prentice H G, Engelhard D, De Bacquer D, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infec Dis 1998; 26: 1098–1103
   PubMed Web of Science ®Google Scholar
• Hovi L, Saarinen-Pihkala U M, Vettenranta K, Saxen H. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 2000; 26: 999–1004
   PubMed Web of Science ®Google Scholar
• Pannuti C S, Gingrich R D, Pfaller M A, Wenzel R P. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol 1991; 9: 77–84
   PubMed Web of Science ®Google Scholar
• Schwartz R S, Mackintosh F R, Schrier S L, Greenberg P L. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984; 53: 411–419
   PubMed Web of Science ®Google Scholar
• Denning D W, Stevens D A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147–1201, Review
   PubMedGoogle Scholar
• De Bock R. Epidemiology of invasive fungal infections in bone marrow transplantation. EORTC Invasive Fungal Infections Cooperative Group. Bone Marrow Transplant 1994; 14(Suppl 5)S1–S2
   Google Scholar
• McWhinney P H, Kibbler C C, Hamon M D, Smith O P, Gandhi L, Berger L A, et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis 1993; 17(3)397–404
   PubMed Web of Science ®Google Scholar
• Wade J C. Treatment of fungal and other opportunistic infections in immunocompromised patients (review). Leukemia 1997; 11(Suppl 4)S38–S39
   Google Scholar
• Noskin G, Pietrelli L, Gurwith M, Bowden R. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients (review). Bone Marrow Transplant 1999; 23: 697–703
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Maury S, Pautas C, Basté J N, Chehata S, Castaigne S, et al. Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone Marrow Transplant 2004; 33: 943–948
   PubMed Web of Science ®Google Scholar
• Wingard J R, Leather H. A new era of antifungal therapy. Biol Blood Marrow Transplant 2004; 10: 73–90
   PubMed Web of Science ®Google Scholar
• Verma A, Williams S, Trifilio S, Zembower T, Mehta J. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone Marrow Transplant 2004; 33: 1065–1066
   PubMed Web of Science ®Google Scholar
• Mattei D, Mordini N, Lo Nigro C, Ghirardo D, Ferrua M T, Osenda M, et al. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation. Bone Marrow Transplant 2002; 30: 967–970
   PubMed Web of Science ®Google Scholar
• Ifran A, Kaptan K, Beyan C. Efficacy of caspofungin in prophylaxis and treatment of an adult leukemic patient with invasive pulmonary aspergillosis in allogeneic stem cell transplantation. Mycoses 2005; 48: 146–148
   PubMed Web of Science ®Google Scholar
• Martino R, Parody R, Fukuda T, Maertens J, Theunissen K, Ho A, et al. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2006; 108: 2928–2936
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex J H, de Pauw B, Bennett J E, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14
   PubMed Web of Science ®Google Scholar
• Robertson M, Larson R A. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med 1988; 84: 233–239
   PubMed Web of Science ®Google Scholar
• Krüger W H, Rüssmann B, de Wit M, Kröger N, Renges H, Sobottka I, et al. Haemopoeitic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B. Acta Haematol 2005; 113: 104–108
   PubMed Web of Science ®Google Scholar
• Fukuda T, Boeckh M, Guthrie K A, Mattson D K, Owens S, Wald A, et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 2004; 10: 494–503
   PubMed Web of Science ®Google Scholar
• van Besien K, Artz A, Smith S, Cao D, Rich S, Godley L, et al. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005; 23: 5728–5738
   PubMed Web of Science ®Google Scholar
• Richard C, Romón I, Baro J, Insunza A, Loyola I, Zurbano F, et al. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. Bone Marrow Transplant 1993; 12: 237–241
   PubMed Web of Science ®Google Scholar
• Michailov G, Laporte J P, Lesage S, Fouillard L, Isnard F, Noel-Walter M P, et al. Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis. Bone Marrow Transplant 1996; 17: 569–572
   PubMed Web of Science ®Google Scholar
• Fukuda T, Boeckh M, Carter R A, Sandmaier B M, Maris M B, Maloney D G, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003; 102: 827–833
   PubMed Web of Science ®Google Scholar
• Avivi I, Oren I, Haddad N, Rowe J, Dann E. Stem cell transplantation post invasive fungal infection is a feasible task. Am J of Hematol 2004; 75: 6–11
   PubMed Web of Science ®Google Scholar
• Martino R, Nomdedéu J, Altés A, Sureda A, Brunet S, Martínez C, et al. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. Bone Marrow Transplant 1994; 13: 265–269
   PubMed Web of Science ®Google Scholar
• Hoover M, Morgan E R, Kletzel M. Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Med Pediatr Oncol 1997; 28: 268–273
   PubMedGoogle Scholar
• Wang J T, Yao M, Tang J L, Chang S C, Hung C C. Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies. J Clin Oncol 2001; 19: 4000–4001
   PubMed Web of Science ®Google Scholar
• Sipsas N V, Kontoyiannis D P. Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis 2006; 42: 1584–1591
   PubMed Web of Science ®Google Scholar